ArticleJournal of medicinal chemistry2024

Discovery of KT-474─a Potent, Selective, and Orally Bioavailable IRAK4 Degrader for the Treatment of Autoimmune Diseases.

Xiaozhang Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.